Genetic Signatures Ltd
ASX:GSS

Watchlist Manager
Genetic Signatures Ltd Logo
Genetic Signatures Ltd
ASX:GSS
Watchlist
Price: 0.7 AUD -2.44% Market Closed
Market Cap: 158.8m AUD
Have any thoughts about
Genetic Signatures Ltd?
Write Note

Intrinsic Value

The intrinsic value of one GSS stock under the Base Case scenario is 1.31 AUD. Compared to the current market price of 0.7 AUD, Genetic Signatures Ltd is Undervalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GSS Intrinsic Value
1.31 AUD
Undervaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genetic Signatures Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GSS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GSS?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Genetic Signatures Ltd

Provide an overview of the primary business activities
of Genetic Signatures Ltd.

What unique competitive advantages
does Genetic Signatures Ltd hold over its rivals?

What risks and challenges
does Genetic Signatures Ltd face in the near future?

Has there been any significant insider trading activity
in Genetic Signatures Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genetic Signatures Ltd.

Provide P/S
for Genetic Signatures Ltd.

Provide P/E
for Genetic Signatures Ltd.

Provide P/OCF
for Genetic Signatures Ltd.

Provide P/FCFE
for Genetic Signatures Ltd.

Provide P/B
for Genetic Signatures Ltd.

Provide EV/S
for Genetic Signatures Ltd.

Provide EV/GP
for Genetic Signatures Ltd.

Provide EV/EBITDA
for Genetic Signatures Ltd.

Provide EV/EBIT
for Genetic Signatures Ltd.

Provide EV/OCF
for Genetic Signatures Ltd.

Provide EV/FCFF
for Genetic Signatures Ltd.

Provide EV/IC
for Genetic Signatures Ltd.

Show me price targets
for Genetic Signatures Ltd made by professional analysts.

What are the Revenue projections
for Genetic Signatures Ltd?

How accurate were the past Revenue estimates
for Genetic Signatures Ltd?

What are the Net Income projections
for Genetic Signatures Ltd?

How accurate were the past Net Income estimates
for Genetic Signatures Ltd?

What are the EPS projections
for Genetic Signatures Ltd?

How accurate were the past EPS estimates
for Genetic Signatures Ltd?

What are the EBIT projections
for Genetic Signatures Ltd?

How accurate were the past EBIT estimates
for Genetic Signatures Ltd?

Compare the revenue forecasts
for Genetic Signatures Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genetic Signatures Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genetic Signatures Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genetic Signatures Ltd compared to its peers.

Compare the P/E ratios
of Genetic Signatures Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Genetic Signatures Ltd with its peers.

Analyze the financial leverage
of Genetic Signatures Ltd compared to its main competitors.

Show all profitability ratios
for Genetic Signatures Ltd.

Provide ROE
for Genetic Signatures Ltd.

Provide ROA
for Genetic Signatures Ltd.

Provide ROIC
for Genetic Signatures Ltd.

Provide ROCE
for Genetic Signatures Ltd.

Provide Gross Margin
for Genetic Signatures Ltd.

Provide Operating Margin
for Genetic Signatures Ltd.

Provide Net Margin
for Genetic Signatures Ltd.

Provide FCF Margin
for Genetic Signatures Ltd.

Show all solvency ratios
for Genetic Signatures Ltd.

Provide D/E Ratio
for Genetic Signatures Ltd.

Provide D/A Ratio
for Genetic Signatures Ltd.

Provide Interest Coverage Ratio
for Genetic Signatures Ltd.

Provide Altman Z-Score Ratio
for Genetic Signatures Ltd.

Provide Quick Ratio
for Genetic Signatures Ltd.

Provide Current Ratio
for Genetic Signatures Ltd.

Provide Cash Ratio
for Genetic Signatures Ltd.

What is the historical Revenue growth
over the last 5 years for Genetic Signatures Ltd?

What is the historical Net Income growth
over the last 5 years for Genetic Signatures Ltd?

What is the current Free Cash Flow
of Genetic Signatures Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genetic Signatures Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genetic Signatures Ltd

Current Assets 52.6m
Cash & Short-Term Investments 36.3m
Receivables 9.6m
Other Current Assets 6.7m
Non-Current Assets 14.7m
PP&E 8.5m
Intangibles 6.2m
Current Liabilities 5.2m
Accounts Payable 3.7m
Other Current Liabilities 1.5m
Non-Current Liabilities 950k
Long-Term Debt 829k
Other Non-Current Liabilities 121k
Efficiency

Earnings Waterfall
Genetic Signatures Ltd

Revenue
14.3m AUD
Cost of Revenue
-7.9m AUD
Gross Profit
6.4m AUD
Operating Expenses
-24.1m AUD
Operating Income
-17.7m AUD
Other Expenses
-141k AUD
Net Income
-17.9m AUD

Free Cash Flow Analysis
Genetic Signatures Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GSS Profitability Score
Profitability Due Diligence

Genetic Signatures Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Negative 1-Year Revenue Growth
Declining ROE
19/100
Profitability
Score

Genetic Signatures Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

GSS Solvency Score
Solvency Due Diligence

Genetic Signatures Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Genetic Signatures Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GSS Price Targets Summary
Genetic Signatures Ltd

Wall Street analysts forecast GSS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSS is 1.12 AUD with a low forecast of 1.11 AUD and a high forecast of 1.16 AUD.

Lowest
Price Target
1.11 AUD
59% Upside
Average
Price Target
1.12 AUD
60% Upside
Highest
Price Target
1.16 AUD
65% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GSS?

Click here to dive deeper.

Dividends

Genetic Signatures Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for GSS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GSS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Genetic Signatures Ltd Logo
Genetic Signatures Ltd

Country

Australia

Industry

Life Sciences Tools & Services

Market Cap

150.7m AUD

Dividend Yield

0%

Description

Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-03-31. The firm is engaged in research and commercialization of identifying individual genetic signatures to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces. The firm is focused on the development and commercialization of its platform technology, 3Base. The Company’s 3Base platform technology provides hospital and pathology laboratories the ability to screen for an array of infectious pathogens, with a degree of specificity, in a rapid throughput (time-to-result) environment. The company also manufactures a Polymerase Chain Reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. The Company’s EasyScreen sample processing kits are used to perform 3Base conversion and nucleic acid extraction and purification.

Contact

NEW SOUTH WALES
Sydney
Heart Research Institute, 7 Eliza Street Newtown
+61298707580.0
geneticsignatures.com

IPO

2015-03-31

Employees

-

Officers

CFO, COO & Company Secretary
Mr. Karl David Pechmann
Executive Director of US Operations & Executive Director
Mr. Michael Anton Aicher BSc, M.B.A., MBA
Chief Executive Officer
Ms. Allison Rossiter
Global Head of People & Culture
Ms. Rebecca Abbatantuono
Global Head of Regulatory Affairs
Ms. Neralie Coulston B.Sc.

See Also

Discover More
What is the Intrinsic Value of one GSS stock?

The intrinsic value of one GSS stock under the Base Case scenario is 1.31 AUD.

Is GSS stock undervalued or overvalued?

Compared to the current market price of 0.7 AUD, Genetic Signatures Ltd is Undervalued by 46%.

Back to Top